CYBERDYNE Inc. (CYBQY)
CYBERDYNE Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Tsukuba, JP. The stock last traded at $1.52, up 19.69% on the session, giving a market capitalisation of $271.1M. On trailing twelve-month figures it carries a trailing P/E of 331.94, a net margin of 4.0%. Its beta of 0.84 implies it has historically moved less than the broad market.
CYBERDYNE Inc., a Japanese technology firm established in 2004 and headquartered in Tsukuba, operates across the entire spectrum of research, development, production, sales, leasing, and maintenance of cutting-edge equipment and systems, catering to both medical and defense sectors. The company is widely recognized for its Hybrid Assistive Limb (HAL) technology, available in medical variants supporting lower limb and single-joint mobility, as well as non-medical models that include options for lower limb, single-joint, and lumbar assistance, alongside its dedicated peripheral devices. Its robotic lineup further extends to automated cleaning units and specialized transport robots designed for internal logistics across factories, offices, and diverse indoor settings. Additionally, CYBERDYNE provides Acoustic X, a rapid light pulse LED array light source facilitating real-time photoacoustic imaging. The company delivers several therapeutic and performance-enhancing programs, such as Cybernics Treatment, which leverages HAL to restore or augment function in individuals suffering from conditions like spinal cord injuries, strokes, and neuromuscular disorders. Other offerings include HAL FIT, designed to strengthen the brain-nerve-musculoskeletal system; MTX Neuro HAL Plus, aimed at boosting athletes' neuro-motor performance; and Neuro HALFIT, which focuses on overall physical capability improvement. Beyond its core product and service lines, CYBERDYNE contributes to disaster relief efforts, provides heavy-duty labor assistance for industrial facilities, and maintains an entertainment division.
CYBERDYNE Inc. is most often compared with the following Healthcare names: